ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,503.20
-2.08%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.4195
0.17%
Brent Oil
83.59
-0.89%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) ニュース

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SEEL
日付受信時刻ニュースソース見出しコード企業名
2020/02/1507 : 47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1503 : 47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1500 : 15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1406 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1406 : 30GlobeNewswire Inc.Seelos Therapeutics Announces Closing of Public Offering of Common StockNASDAQ:SEELSeelos Therapeutics Inc
2020/02/1306 : 06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1220 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1207 : 15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1120 : 09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/1110 : 00GlobeNewswire Inc.Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common StockNASDAQ:SEELSeelos Therapeutics Inc
2020/02/1105 : 18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/0720 : 06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/02/0520 : 03Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/3020 : 01Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/3020 : 01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/2822 : 02GlobeNewswire Inc.Seelos Therapeutics Announces Update to Parkinson’s Disease Program SLS-007NASDAQ:SEELSeelos Therapeutics Inc
2020/01/2221 : 30GlobeNewswire Inc.Seelos Therapeutics Announces Updates to SLS-005 (trehalose) Programs for Europe and U.S.NASDAQ:SEELSeelos Therapeutics Inc
2020/01/2220 : 03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/1708 : 29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/1021 : 31GlobeNewswire Inc.Seelos Therapeutics Announces Interim Data from Phase I Study of Intranasal Racemic Ketamine (SLS-002)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0806 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0806 : 33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0806 : 32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0806 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0806 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0622 : 02GlobeNewswire Inc.Seelos Therapeutics Schedules Type C Meeting with FDA to Discuss Intranasal Racemic Ketamine Program (SLS-002)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0406 : 34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
2020/01/0406 : 34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SEELSeelos Therapeutics Inc
2019/12/1621 : 00GlobeNewswire Inc.Sorrento Announces Dr. Robin Smith as New Member of the Board of DirectorsNASDAQ:SEELSeelos Therapeutics Inc
2019/12/1322 : 30GlobeNewswire Inc.Seelos Therapeutics to Participate in 33rd Annual National MPS Society Family ConferenceNASDAQ:SEELSeelos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SEEL

最近閲覧した銘柄

COIN
ETHUSD
Ethereum
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
CCOM
US500
US 500
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
FX
USDEUR
US Dollar vs Euro
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有